GEO MATHEW: Open Payments
NPI 1215990205 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,207 in 255 payments from 18 companies in 2025. Trend: 2023 $2,858 · 2024 $3,644 · 2025 $5,207
Food & beverage: $5,122Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $857 |
| Janssen Biotech, Inc. | 31 | $741 |
| Aimmune Therapeutics, Inc. | 52 | $684 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 36 | $598 |
| Ardelyx, Inc. | 24 | $426 |
| Gilead Sciences, Inc. | 11 | $423 |
| Lilly USA, LLC | 8 | $272 |
| Medtronic, Inc. | 3 | $256 |
| Madrigal Pharmaceuticals | 8 | $222 |
| Ipsen Biopharmaceuticals, Inc | 5 | $162 |
Products named: TREMFYA, VOWST, XIFAXAN, IBSRELA, RINVOQ, VENASEAL, REZDIFFRA, DUPIXENT.
Industry payments across CA — which companies pay providers there.
